---
category: news
title: "Sarepta Therapeutics and Dyno Therapeutics Announce Agreement to Develop Next-Generation Gene Therapy Vectors for Muscle Diseases"
excerpt: "Agreement leverages Sarepta's leadership in gene therapy for neuromuscular and cardiovascular diseases and Dyno's CapsidMap artificial intelligence platform to design"
publishedDateTime: 2020-05-11T11:00:00Z
webUrl: "https://www.benzinga.com/pressreleases/20/05/g15998024/sarepta-therapeutics-and-dyno-therapeutics-announce-agreement-to-develop-next-generation-gene-ther"
ampWebUrl: "https://amp.benzinga.com/amp/content/15998024"
cdnAmpWebUrl: "https://amp-benzinga-com.cdn.ampproject.org/c/s/amp.benzinga.com/amp/content/15998024"
type: article
quality: 10
heat: -1
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "Novartis, Sarepta join Dynoâ€™s enterprise to boldly go to new gene therapy frontier"
    excerpt: "Dyno Therapeutics Inc., an early stage gene therapy firm applying artificial intelligence to advanced capsid engineering, has entered partnerships with Novartis AG and Sarepta Therapeutics Inc., in ophthalmic indications and muscle diseases,"
    publishedDateTime: 2020-05-11T23:09:00Z
    webUrl: "https://www.bioworld.com/articles/434990-novartis-sarepta-join-dynos-enterprise-to-boldly-go-to-new-gene-therapy-frontier"
    type: article
    provider:
      name: BioWorld
      domain: bioworld.com
    quality: 33
    images:
      - url: "https://www.bioworld.com/ext/resources/Stock-images/Deals-and-MAs/Deal-partnership-chain-link.png?height=635&t=1588276656&width=1200"
        width: 847
        height: 635

secured: "2JDUCG7v/2CuNJB1DYsuwllVlxFI/p4DgLhJ2EP0UVcVj4fKGM53HYwel3kWtf3ycJaR7TtFrjsueZJcQ0+Wte00xko9YAv3iRkASSbNb8RM7GQz243feHg5P/bQx2v4UtgJBMqSckrWvaV3oJZpC6kbMAtMZaISz7ttWo7Kpurw6QAWRzDdampgwpqoSs3Ifbs857Xm0OhIwGURFq+40IZJuc5uNsmSdKUdRMD8degO8LjMY8U8xH+EOuyfOp/JpTJSchD07eUVIV2r8wJfRDqNVA6BGOh+nr++PztTF98VVHkj/RPU2ibCYu7qeDnJ;8s+Kt7JgmAegRp5NEyUmVg=="
---

